AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,451,000 | -58.5% | 202,518 | -47.5% | 0.01% | -57.1% |
| Q3 2016 | $20,375,000 | +92.2% | 385,747 | +52.5% | 0.02% | +90.9% |
| Q2 2016 | $10,600,000 | +2007.4% | 253,023 | +1942.6% | 0.01% | +1000.0% |
| Q1 2016 | $503,000 | -39.9% | 12,387 | -3.9% | 0.00% | 0.0% |
| Q4 2015 | $837,000 | +100.2% | 12,896 | +118.0% | 0.00% | – |
| Q3 2015 | $418,000 | +137.5% | 5,916 | +274.2% | 0.00% | – |
| Q2 2015 | $176,000 | -99.5% | 1,581 | -99.6% | 0.00% | -100.0% |
| Q1 2015 | $34,750,000 | -18.9% | 368,499 | -3.7% | 0.04% | -16.3% |
| Q4 2014 | $42,868,000 | +140.5% | 382,619 | +31.7% | 0.04% | +138.9% |
| Q3 2014 | $17,826,000 | +161.9% | 290,562 | +95.6% | 0.02% | +200.0% |
| Q2 2014 | $6,807,000 | +127.4% | 148,557 | +94.3% | 0.01% | +100.0% |
| Q1 2014 | $2,993,000 | +36.1% | 76,456 | -16.7% | 0.00% | +50.0% |
| Q4 2013 | $2,199,000 | -14.1% | 91,797 | +0.2% | 0.00% | -33.3% |
| Q3 2013 | $2,561,000 | – | 91,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |